ValerieReneeSuskiDO

Neurology • Pittsburgh, PA

Assistant Professor, Neurology, University of Pittsburgh School of Medicine

Join to view full profile

Dr. Suski is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Suski's full profile

Already have an account?

Office
3471 Fifth Avenue
811 Kaufmann Building
Pittsburgh, PA 15213
Phone+1 412-692-4600

Fax+1 412-692-4907
Is this information wrong?

Education & Training

Duke University HospitalFellowship, Neuromuscular Medicine (Neurology), 2006 - 2007
Virginia Commonwealth University Health SystemResidency, Neurology, 2003 - 2006
Virginia Commonwealth University Health SystemResidency, Internal Medicine, 2002 - 2003
Lake Erie College of Osteopathic Medicine - Seton HillClass of 2002

Certifications & Licensure

PA State License 2007 - 2024
VA State License 2002 - 2006
American Board of Psychiatry and Neurology Neurology

Clinical Trials

A Study of the Novel Drug Dimebon in Patients With Huntington's Disease Start of enrollment: 2007 Jul 01
Completed
Phase 2
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E) Start of enrollment: 2009 Sep 01
Terminated
Phase 3
Open-label Extension Study of Pridopidine (ACR16) in the Symptomatic Treatment of Huntington Disease Start of enrollment: 2011 Mar 24
Completed
Phase 2
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort Start of enrollment: 2012 Jul 01
Recruiting
A Phase 2, to Evaluating the Safety and Efficacy of Pridopidine Vs Placebo for Symptomatic Treatment in Patients With Huntington's Disease Start of enrollment: 2014 Feb 28
Completed
Phase 2
Tolerability, Safety, and Activity of SRX246 in Irritable Subjects With Huntington's Disease Start of enrollment: 2016 May 10
Completed
Phase 2
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension Start of enrollment: 2016 Feb 11
Completed
Phase 4
Development of the Virtual Unified Huntington's Disease Rating Scale Start of enrollment: 2022 Sep 22
Completed
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

3 citations
Differential tractography as a dynamic imaging biomarker: A methodological pilot study for Huntington's disease.
Jessica V Barrios-Martinez, David T Fernandes-Cabral, Kumar Abhinav, Juan C Fernandez-Miranda, Yue-Fang Chang, Valerie Suski, Fang-Cheng Yeh, Robert M Friedlander> ;Neuroimage. Clinical. 2022 Jan 1
74 citations
Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial
Michael A. Schwarzschild, Alberto Ascherio, Cindy Casaceli, Gary C. Curhan, Rebecca Fitzgerald, Cornelia Kamp, Codrin Lungu, Eric A. Macklin, Kenneth Marek, Dariush Mo...> ;JAMA. 2021 Sep 14
10 citations
Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical Trial.
Michael J Brownstein, Neal G. Simon, Jeffrey D. Long, Jon W. Yankey, Hilda T Maibach, Merit Cudkowicz, Christopher S. Coffey, Robin Conwit, Codrin Lungu, Karen E. Ande...> ;Journal of Clinical Medicine. 2020 Nov 16
56 citations
Differential tractography as a track-based biomarker for neuronal injury.
Fang-Cheng Yeh, Islam M. Zaydan, Valerie Suski, David Lacomis, R. Mark Richardson, Joseph C. Maroon, Jessica Barrios-Martinez> ;Neuroimage. 2019 Nov 15
161 citations
Phase 2 trial of ibudilast in progressive multiple sclerosis
Robert J. Fox, Christopher S. Coffey, Robin Conwit, Merit Cudkowicz, Trevis Gleason, Andrew D. Goodman, Eric C. Klawiter, K. Matsuda, Michelle McGovern, Robert T. Nais...> ;The New England Journal of Medicine. 2018 Aug 30
32 citations
Outcomes of Interventional-MRI Versus Microelectrode Recording-Guided Subthalamic Deep Brain Stimulation.
Philip S. Lee, Gregory M. Weiner, Danielle Corson, Jessica Kappel, Yuefang Chang, Valerie Suski, Sarah B. Berman, Houman Homayoun, Amber D. Van Laar, Donald J. Crammon...> ;Frontiers in Neurology. 2018 Apr 11
85 citations
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease
Andrew McGarry, Michael P. McDermott, Karl Kieburtz, Elisabeth A. deBlieck, Flint Beal, Karen Marder, Christopher A. Ross, Ira Shoulson, Peter R. Gilbert, William Mall...> ;Neurology. 2017 Jan 10
51 citations
Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis
Robert J. Fox, Christopher S. Coffey, Merit Cudkowicz, Trevis Gleason, Andrew D. Goodman, Eric C. Klawiter, Kazuko Matsuda, Michelle McGovern, Robin Conwit, Robert T. ...> ;Contemporary Clinical Trials. 2016 Sep 1
Vestibular function in families with inherited autosomal dominant hearing loss.
Street, V. A., Kallman, J. C., Strombom, P. D., Bramhall, N. F., Phillips, J. O.> ;J Vestib Res. 2008
80 citations
Advanced diffusion MRI fiber tracking in neurosurgical and neurodegenerative disorders and neuroanatomical studies: A review
Kumar Abhinav, Fang-Cheng Yeh, Sudhir Pathak, Valerie Suski, David Lacomis, Robert M. Friedlander, Juan C. Fernandez-Miranda> ;Biochimica Et Biophysica Acta. 2014 Nov 1
21 citations
The relevance of age and disease duration for intervention with subthalamic nucleus deep brain stimulation surgery in Parkinson disease
Brodie Parent, Nasir R Awan, Sarah B. Berman, Valerie Suski, Robert Y. Moore, Donald J. Crammond, Douglas Kondziolka> ;Journal of Neurosurgery. 2011 Apr 1
3 citations
Expression of the Human Hepatocyte Growth Factor cDNA in Primary Cultures of Rat Hepatocytes
Dorothee M. Runge, William C. Bowen, S. L. Katyal, Dieter Runge, Valerie Suski, George K. Michalopoulos> ;Biochemical and Biophysical Research Communications. 1999 Apr 2
Join now to see all